Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.

2 references·10 citing·32 second hop

FromToDepth

this work references cited by second hop

References

2010Cost Accounting: A Managerial Emphasis,2,496 cited
1977Foundations of Cost-Effectiveness Analysis for Health and Medical Practices2,118 cited

Cited by

1995Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer151 cited
1994Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide100 cited
1998Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.75 cited
2002Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer74 cited
2000Decision Framework for Chemotherapeutic Interventions for Metastatic Non-Small-Cell Lung Cancer71 cited
2002Economic Analysis of the TAX 317 Trial: Docetaxel Versus Best Supportive Care as Second-Line Therapy of Advanced Non-Small-Cell Lung Cancer71 cited
1998Economic issues in lung cancer: a review.70 cited
1999Cost-Utility Analysis of Chemotherapy Using Paclitaxel, Docetaxel, or Vinorelbine for Patients With Anthracycline-Resistant Breast Cancer57 cited
2004Economics of the clinical management of lung cancer in France: an analysis using a Markov model56 cited
2009Improving the Methodologic and Ethical Validity of Best Supportive Care Studies in Oncology: Lessons From a Systematic Review49 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work